Conferences
SIU 2017: The Prognostic Implication of Body Mass Index on Postoperative Survival Outcomes in Non-Metastatic Renal Cell Carcinoma
October 23, 2017
SIU 2017: The Predictive Value of Preoperative AST/ALT Ratio in Renal Cell Carcinoma Patients – A Multicenter Study
October 23, 2017
SIU 2017: Cytoreductive Nephrectomy in the Era of Tyrosine Kinase Inhibitors: Is It the Standard?
October 23, 2017
SIU 2017: Is It Always Necessary to Perform Restaging TUR for cT1 Urothelial Carcinoma of the Bladder?
October 23, 2017
AUA QI Summit 2017: Practical Issues in CT Dose Optimization
October 23, 2017
AUA QI Summit 2017: Follow-up After an ED Visit for Acute Renal Colic/Toolkit from AUA Imaging Stewardship Workgroup
October 23, 2017
SIU 2017: The Role of Lymphadenectomy in the Oligometastatic and Salvage Prostate Cancer Setting
October 23, 2017
AUA QI Summit 2017: E-QUAL From the Urologist’s Perspective
October 23, 2017
SIU 2017: Differences in Clinical and Pathological Characteristics Between Patients with Small Renal Masses (T1a) and Larger Renal Masses
October 23, 2017
AUA QI Summit 2017: Dose Optimization in Stone Evaluation: DOSE
October 23, 2017
SIU 2017: Renal Masses at Presentation: Clinical and Treatment Patterns Among Continents
October 23, 2017
SIU 2017: The Utility of Subsequent Prostate Biopsies for the Active Surveillance of Prostate Cancer when Genomics and MRI Are Negative
October 23, 2017
SIU 2017: TP53 p. R337H Germline Mutation Analysis in Patients with Clear Cell Renal Cell Carcinoma
October 23, 2017